Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas

Summary

This study is an extension to re-treat partial and non-responders from the previously approved Phase 1 MCS-AFP protocols IRB #12-009716 (Crohn's Disease perianal fistulas) and 15-003200 (cryptoglandular perianal fistulas).

Timeline

Start

2017-07-20

Primary completion

2019-12-10

Completion

2019-12-10

Drugs

Indications